Infectious diseases researcher H. Keipp Talbot, MD, MPH, has been appointed chair of the Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention.

Fibrosis is an all-too-common medical condition that globally is responsible for 800 million cases of chronic kidney disease and two million deaths from chronic liver diseases each year.

Anna Hemnes, MD, professor of Medicine, has been named director of the Division of Allergy, Pulmonary and Critical Care Medicine, physician-in-chief of the Vanderbilt Lung Institute and director of the Center for Lung Research.

John Koethe, MD, MSCI, associate professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center, has been appointed director and principal investigator of the Tennessee Center for AIDS Research (CFAR). 

Koethe succeeds Simon Mallal, MBBS, the Major E.B. Stahlman Chair in Infectious Diseases and Inflammation at VUMC, who has directed the center since it was reorganized in 2015.

Bariatric surgery can lead to significant cardiometabolic health improvements using a variety of measures, including blood pressure, cholesterol, glucose and hemoglobin A1C, according to a new study published in the Journal of the Endocrine Society.

The Department of Medicine is excited to share the results of the 2024 National Resident Matching Program (NRMP) Match, which were made public on Friday, March 15, during the highly anticipated Match Day celebrations.

A new study led by Vanderbilt University Medical Center researchers has identified key immune cell populations that predict how well pediatric hematopoietic stem cell transplant (HCT) recipients will respond to the influenza vaccine.

Vanderbilt University School of Medicine ranked 10th in the nation in total research grant support provided by the National Institutes of Health (NIH) in fiscal year 2023, according to figures compiled by the nonprofit Blue Ridge Institute for Medical Research.

More than 60 current clinical trials are using molecules called F2-isoprostanes (F2-IsoPs) as biomarkers of endogenous oxidative injury. Previous studies have shown that F2-IsoPs are increased in multiple oxidative stress-related diseases, including cardiovascular disease, neurodegeneration, diabetes, certain types of cancer and COVID-19.

A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury (AKI), which occurs in more than 1 in 5 hospitalized adults worldwide.